# GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence

> **NCT02633982** · — · UNKNOWN · sponsor: **Japan Cardiovascular Research Foundation** · enrollment: 5000 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02633982
- **Lead sponsor:** Japan Cardiovascular Research Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2015-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633982, "GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02633982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*